Pierluigi Porcu, M.D.
Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Thomas Jefferson University

Pierluigi Porcu, M.D. is Director of the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation in the Department of Medical Oncology at Thomas Jefferson University.

Dr. Porcu came to Jefferson from The Ohio State University in Columbus, where he held the position of Professor of Medicine with tenure and was a member of the Viral Oncology Program of The Ohio State University Comprehensive Cancer Center. Dr. Porcu earned his undergraduate degree from Liceo Classico Lagrange, Vercelli, Italy and received his MD from the University of Torino. Dr. Porcu came to Jefferson in 1990 for a postdoctoral research fellowship in our Department of Microbiology-Immunology, ultimately rising to the rank of Research Instructor. He completed his internal medicine residency and hematology/oncology fellowship at Indiana University, Indianapolis. In 1999, Dr. Porcu joined the faculty of The Ohio State University as an Assistant Professor, rising to the rank of Professor with tenure.

Dr. Porcu is a lymphoma-focused hematologic oncologist. He has led a multidisciplinary team of clinicians, researchers and nurses with the goal of discovering causes and risk factors for T-cell and NK-cell lymphomas; developing lymphoma-specific oncology practice models that integrate clinical care, research and mentoring; and bringing new therapies to the clinic through biomarker research and clinical trials. He was the Director of the Cutaneous Lymphoma Program, an integrated translational research program that included a multimodality cutaneous lymphoma clinic jointly staffed by hematologists, dermatologists and pathologists, all with a special expertise in skin lymphomas. Dr. Porcu’s efforts have also focused on the role of the Epstein Barr Virus in a subset of T-cell and NK-cell lymphomas that are rare in North America but common in Asia and South America.

Dr. Porcu has a long track record of advocacy and education for patients with cutaneous lymphoma and has been a successful fundraiser, creating Team CTCL, a 105-member cycling team that participates in Pelotonia, one of the most successful cancer fundraising events in the United States. From 2011 to 2014, Dr. Porcu was listed among the U.S. News & World Report Top Cancer Doctors in America, and in 2015, he was listed as one of Newsweek’s Top Hematology Doctors.